	US 11,965,895 B2
	Methods and devices female health monitoring
Anna Villarreal, Brookline, MA (US)
Assigned to LIFESTORY HEALTH, INC., Brookline, MA (US)
Filed by Lifestory Health Inc., Brookline, MA (US)
Filed on Dec. 3, 2021, as Appl. No. 17/541,898.
Application 17/541,898 is a continuation of application No. 15/534,218, granted, now 11,193,942, previously published as PCT/US2015/064501, filed on Dec. 8, 2015.
Claims priority of provisional application 62/240,334, filed on Oct. 12, 2015.
Claims priority of provisional application 62/089,644, filed on Dec. 9, 2014.
Prior Publication US 2022/0120763 A1, Apr. 21, 2022
This patent is subject to a terminal disclaimer.
Int. Cl. G01N 33/68 (2006.01)

CPC G01N 33/6893 (2013.01) [G01N 2800/60 (2013.01)]

4 Claims

1. A method for evaluating one or more disease- or health-related biomarkers proteins in a female subject, comprising:

(a) obtaining a first sample of the female subject's menstrual fluid on a collection device;

(b) detecting a presence, absence, or level of one or more disease- or health-related biomarkers proteins in the first sample; and

(c) obtaining a subsequent menstrual fluid sample and detecting a presence, absence, or level of the one or more disease- or health related biomarkers- proteins detected in the first sample and the subsequent sample,

and wherein the biomarker proteins in the first sample and subsequent sample are Fascin, or Activin A.